You are here: Industry Insights > COVID-19 vaccine

News List

Pfizer and BioNTech to extend rolling submission for Covid-19 vaccine Pharmaceutical-Technology
February 15, 2022
Pfizer and BioNTech are set to extend their rolling submission to the US Food and Drug Administration (FDA) for amending the emergency use authorization (EUA) of the Covid-19 vaccine to include children aged six months to four years.
AstraZeneca revenues soar with nearly $4bn in Covid-19 vaccine sales Pharmaceutical-Technology
February 11, 2022
The drugmaker, which is just beginning to profit from its Covid-19 vaccine, has recorded $37.4bn in revenue.
2021 — the year UK biotechs broke investment records CPhIonline
February 10, 2022
Initial Public Offerings totalled £1,304 million, an increase of 434% from 2020, but more needs to be done to connect the UK's life sciences and finance sectors.
Second COVID-19 vaccine ‘Spikevax’ is approved by the FDA EuropeanPharmaceuticalReview
February 10, 2022
The FDA has approved a second vaccine, marketed as Spikevax, shown to be 93 percent effective in preventing COVID-19.
Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* prnasia
February 07, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products Regulatory Agency...
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine prnasia
February 07, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases...
Novavax gets New Zealand’s provisional approval for Covid-19 vaccine Pharmaceutical-Technology
February 07, 2022
New Zealand’s Medsafe has granted provisional approval for Novavax’s adjuvanted Covid-19 vaccine, NVX-CoV2373, for active immunisation to prevent Covid-19 in individuals aged 18 years and above.
FDA takes key action by approving second COVID-19 vaccine WorldPharmaNews
February 07, 2022
The U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine.
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age WorldPharmaNews
January 28, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age.
Novavax Covid-19 vaccine to be rolled out in Australia from next month Pharmaceutical-Technology
January 26, 2022
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page